Italian Life Sciences Database

CORK, Ireland, Aug. 22, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) have announced positive top-line results from the Phase 3 ATLAS-2M study of the investigational, long-acting two-drug injectable regimen of its rilpivirine and ViiV Healthcare's... Read more ››

By: PR Newswire Association LLC. - 22 Aug 2019

Steward Health Care Signs Long-Term Agreement with B. Braun for IV Solutions and Infusion Pumps

By: Nasdaq / GlobenewsWire - 21 Aug 2019

Cassiopea Announces FDA Submission of New Drug Application for Clascoterone Cream 1%, the First New Mechanism of Action for Acne in Nearly 40 Years

LAINATE, Italy, Aug. 20, 2019 /PRNewswire/ -- Cassiopea SpA (SIX: SKIN), a specialty pharmaceutical company developing and commercializing prescription drugs with novel mechanisms of action (MOA) to address long-standing and essential dermatological conditions, announced today that it has submitted... Read more ››

By: PR Newswire Association LLC. - 20 Aug 2019

Related companies: Cassiopea S.p.A.

Novo Nordisk's operating profit increased by 12% in Danish kroner and by 6% at constant exchange rates (CER) in the first six months of 2019

By: Nasdaq / GlobenewsWire - 09 Aug 2019

ALK announces new epinephrine auto-injector strategy based on innovative new product for the USA

By: Nasdaq / GlobenewsWire - 09 Aug 2019

« 1 2 3 4 5 6 7 8 »

Looking for companies outside of Italy?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

October 2019
- Rennes: NutrEvent
- San Francisco: BIO Investor Forum
- Melbourne: Biotech-Pharma Product and Company Valuation - introduction

See Events »

Add an Event »

Latest company news

Novo Nordisk A/S – Share repurchase programme
14 Oct 2019 (Nasdaq / GlobenewsWire)

Johnson & Johnson Commits $500 Million Investment Over Four Years to Help End the Epidemics of HIV and Tuberculosis
11 Oct 2019 (PR Newswire Association LLC.)

Novo Nordisk A/S – Share repurchase programme
07 Oct 2019 (Nasdaq / GlobenewsWire)

News in the Life Sciences Industry

Novo Nordisk A/S – Share repurchase programme

Germany becomes first launch market for ALK’s tree SLIT-tablet

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff

B. Braun Interventional Systems Expands its Congenital and Structural Heart Portfolio With the EmeryGlide™ MR Conditional Guidewire From Nano4Imaging

Sanofi : U.S. District Court invalidates Amgen patent claims targeting PCSK9

SI-BONE to Present at the 17th Annual Morgan Stanley Global Healthcare Conference on September 10, 2019

Novo Nordisk A/S – Share repurchase programme

Janssen Reports Positive Top-line Phase 3 Study Results of Investigational, Long-acting Injectable HIV Treatment Regimen Administered Every Two Months

Steward Health Care Signs Long-Term Agreement with B. Braun for IV Solutions and Infusion Pumps

Cassiopea Announces FDA Submission of New Drug Application for Clascoterone Cream 1%, the First New Mechanism of Action for Acne in Nearly 40 Years

Novo Nordisk A/S – Share repurchase programme

Sanofi: information concerning the total number of voting rights and shares, July 2019

Novo Nordisk A/S: Securities lawsuit filed in Denmark against Novo Nordisk

B. Braun Successfully Integrates with Epic at Prime Healthcare – Huntington Beach Hospital

Six-month interim report (Q2) 2019

Trading in Novo Nordisk shares by board members, executives and associated persons on 9 August 2019

ALK upgrades its full-year financial outlook due to strong growth

B. Braun Awarded Best Research Article of 2018 by BI&T

Novo Nordisk's operating profit increased by 12% in Danish kroner and by 6% at constant exchange rates (CER) in the first six months of 2019

ALK announces new epinephrine auto-injector strategy based on innovative new product for the USA

Looking for companies outside of Italy?

Partners

Upcoming Life Sciences Events

Latest company news